These data indicate that melanoma fucosylation substantially shapes the itIC landscape, correlates with increased intratumoral CD3+ T cells in mice and humans and can be boosted by oral l-fuc to increase itICs and suppress BRAF- and NRAS-mutant melanomas. The gene discussed is NRAS; the disease is melanoma.